Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Analysis of Long-term (Investment) Activity Ratios
Quarterly Data

Microsoft Excel

Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.

Long-term Activity Ratios (Summary)

Boston Scientific Corp., long-term (investment) activity ratios (quarterly data)

Microsoft Excel
Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Net fixed asset turnover 5.26 5.18 5.53 5.49 5.37 5.28 5.44 5.38 4.93 4.76 4.90 4.89 5.14 5.16 5.35 5.54 5.58 5.51 — — —
Total asset turnover 0.40 0.39 0.39 0.38 0.38 0.37 0.36 0.36 0.33 0.32 0.33 0.33 0.36 0.35 0.39 0.41 0.42 0.47 — — —
Equity turnover 0.73 0.72 0.71 0.71 0.73 0.72 0.70 0.70 0.64 0.65 0.65 0.65 0.78 0.77 1.07 1.07 1.08 1.13 — — —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Boston Scientific Corp. net fixed asset turnover ratio deteriorated from Q3 2022 to Q4 2022 but then slightly improved from Q4 2022 to Q1 2023.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Boston Scientific Corp. total asset turnover ratio deteriorated from Q3 2022 to Q4 2022 but then improved from Q4 2022 to Q1 2023 exceeding Q3 2022 level.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Boston Scientific Corp. equity turnover ratio improved from Q3 2022 to Q4 2022 and from Q4 2022 to Q1 2023.

Net Fixed Asset Turnover

Boston Scientific Corp., net fixed asset turnover calculation (quarterly data)

Microsoft Excel
Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in millions)
Net sales 3,389 3,242 3,170 3,244 3,026 3,127 2,932 3,077 2,752 2,708 2,659 2,003 2,543 2,904 2,707 2,631 2,493 2,561 2,393 2,490 2,379
Property, plant and equipment, net 2,478 2,446 2,273 2,246 2,265 2,252 2,109 2,082 2,053 2,084 2,064 2,079 2,098 2,079 1,942 1,820 1,782 1,782 1,730 1,715 1,700
Long-term Activity Ratio
Net fixed asset turnover1 5.26 5.18 5.53 5.49 5.37 5.28 5.44 5.38 4.93 4.76 4.90 4.89 5.14 5.16 5.35 5.54 5.58 5.51 — — —
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 4.47 4.76 5.18 5.17 5.00 4.81 4.79 4.56 4.23 3.83 3.74 3.77 4.06 3.97 — — — — — — —
Cigna Group 47.44 47.53 47.84 48.61 47.95 46.73 41.42 40.56 39.29 37.85 37.05 36.02 35.37 34.45 — — — — — — —
CVS Health Corp. 25.63 24.98 24.90 24.05 23.26 22.56 22.24 21.90 21.42 21.25 21.48 21.52 21.49 21.24 — — — — — — —
Danaher Corp. 7.61 7.96 8.40 8.12 7.94 7.77 7.71 7.84 7.59 6.83 6.68 6.35 6.03 7.78 — — — — — — —
Elevance Health Inc. 36.14 36.07 36.22 36.17 35.81 34.94 34.54 34.17 34.94 34.69 34.61 32.74 32.30 32.92 — — — — — — —
Humana Inc. 29.40 28.71 28.37 28.64 27.05 26.97 27.83 29.47 31.04 32.05 32.90 33.07 33.20 32.93 — — — — — — —
Intuitive Surgical Inc. 2.49 2.62 2.73 2.83 3.00 3.04 3.16 3.13 2.86 2.76 2.85 3.00 3.36 3.52 — — — — — — —
Medtronic PLC 5.88 5.85 6.05 6.13 6.12 5.77 5.56 5.64 5.72 5.99 6.52 6.50 6.51 6.54 6.65 6.70 6.62 6.51 — — —
UnitedHealth Group Inc. 31.35 31.81 33.07 32.33 32.16 31.81 31.77 30.94 30.76 29.64 30.80 30.30 29.91 27.60 — — — — — — —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q1 2023 Calculation
Net fixed asset turnover = (Net salesQ1 2023 + Net salesQ4 2022 + Net salesQ3 2022 + Net salesQ2 2022) ÷ Property, plant and equipment, net
= (3,389 + 3,242 + 3,170 + 3,244) ÷ 2,478 = 5.26

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Boston Scientific Corp. net fixed asset turnover ratio deteriorated from Q3 2022 to Q4 2022 but then slightly improved from Q4 2022 to Q1 2023.

Total Asset Turnover

Boston Scientific Corp., total asset turnover calculation (quarterly data)

Microsoft Excel
Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in millions)
Net sales 3,389 3,242 3,170 3,244 3,026 3,127 2,932 3,077 2,752 2,708 2,659 2,003 2,543 2,904 2,707 2,631 2,493 2,561 2,393 2,490 2,379
Total assets 32,892 32,469 31,947 32,189 32,337 32,229 31,877 31,168 30,900 30,777 30,845 30,823 30,113 30,565 26,756 24,309 23,802 20,999 20,379 19,615 19,202
Long-term Activity Ratio
Total asset turnover1 0.40 0.39 0.39 0.38 0.38 0.37 0.36 0.36 0.33 0.32 0.33 0.33 0.36 0.35 0.39 0.41 0.42 0.47 — — —
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.56 0.59 0.62 0.61 0.60 0.57 0.57 0.55 0.51 0.48 0.47 0.46 0.48 0.47 — — — — — — —
Cigna Group 1.23 1.25 1.24 1.17 1.15 1.11 1.09 1.07 1.06 1.02 0.97 0.96 0.99 0.98 — — — — — — —
CVS Health Corp. 1.38 1.41 1.36 1.33 1.28 1.25 1.21 1.20 1.18 1.16 1.14 1.12 1.13 1.15 — — — — — — —
Danaher Corp. 0.36 0.37 0.39 0.38 0.36 0.35 0.34 0.34 0.33 0.29 0.28 0.27 0.26 0.29 — — — — — — —
Elevance Health Inc. 1.46 1.51 1.48 1.47 1.42 1.41 1.35 1.33 1.29 1.39 1.34 1.28 1.31 1.33 — — — — — — —
Humana Inc. 1.74 2.15 1.80 1.91 1.86 1.87 1.78 2.08 2.08 2.17 1.90 1.82 1.94 2.21 — — — — — — —
Intuitive Surgical Inc. 0.49 0.48 0.46 0.44 0.43 0.42 0.42 0.42 0.39 0.39 0.41 0.43 0.47 0.46 — — — — — — —
Medtronic PLC 0.35 0.35 0.35 0.35 0.34 0.32 0.29 0.29 0.30 0.32 0.33 0.34 0.34 0.34 0.34 0.34 0.33 0.33 — — —
UnitedHealth Group Inc. 1.18 1.31 1.29 1.32 1.33 1.34 1.30 1.29 1.27 1.30 1.31 1.28 1.29 1.38 — — — — — — —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q1 2023 Calculation
Total asset turnover = (Net salesQ1 2023 + Net salesQ4 2022 + Net salesQ3 2022 + Net salesQ2 2022) ÷ Total assets
= (3,389 + 3,242 + 3,170 + 3,244) ÷ 32,892 = 0.40

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Boston Scientific Corp. total asset turnover ratio deteriorated from Q3 2022 to Q4 2022 but then improved from Q4 2022 to Q1 2023 exceeding Q3 2022 level.

Equity Turnover

Boston Scientific Corp., equity turnover calculation (quarterly data)

Microsoft Excel
Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selected Financial Data (US$ in millions)
Net sales 3,389 3,242 3,170 3,244 3,026 3,127 2,932 3,077 2,752 2,708 2,659 2,003 2,543 2,904 2,707 2,631 2,493 2,561 2,393 2,490 2,379
Stockholders’ equity 17,850 17,573 17,640 17,251 16,735 16,622 16,461 15,942 15,719 15,326 15,564 15,616 13,804 13,877 9,699 9,425 9,233 8,726 8,289 7,744 7,030
Long-term Activity Ratio
Equity turnover1 0.73 0.72 0.71 0.71 0.73 0.72 0.70 0.70 0.64 0.65 0.65 0.65 0.78 0.77 1.07 1.07 1.08 1.13 — — —
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 1.12 1.19 1.26 1.25 1.26 1.20 1.23 1.19 1.11 1.06 1.03 1.03 1.06 1.03 — — — — — — —
Cigna Group 4.09 4.00 3.98 3.88 3.81 3.66 3.56 3.40 3.36 3.16 3.24 3.24 3.39 3.36 — — — — — — —
CVS Health Corp. 4.62 4.53 4.45 4.08 4.05 3.87 3.82 3.79 3.81 3.86 3.86 3.87 4.01 4.00 — — — — — — —
Danaher Corp. 0.60 0.63 0.67 0.66 0.65 0.65 0.65 0.62 0.61 0.56 0.54 0.52 0.58 0.59 — — — — — — —
Elevance Health Inc. 4.27 4.29 4.22 4.13 3.97 3.80 3.71 3.65 3.65 3.64 3.43 3.26 3.41 3.25 — — — — — — —
Humana Inc. 5.74 6.04 5.62 5.77 5.63 5.15 4.96 5.34 5.48 5.54 4.65 4.86 5.44 5.35 — — — — — — —
Intuitive Surgical Inc. 0.57 0.56 0.53 0.50 0.49 0.48 0.48 0.48 0.45 0.45 0.47 0.50 0.54 0.54 — — — — — — —
Medtronic PLC 0.59 0.60 0.60 0.61 0.61 0.59 0.55 0.56 0.56 0.57 0.60 0.61 0.61 0.61 0.61 0.61 0.60 0.59 — — —
UnitedHealth Group Inc. 4.10 4.14 4.19 4.18 4.06 3.98 3.95 3.92 3.94 3.90 3.85 3.87 4.29 4.17 — — — — — — —

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

1 Q1 2023 Calculation
Equity turnover = (Net salesQ1 2023 + Net salesQ4 2022 + Net salesQ3 2022 + Net salesQ2 2022) ÷ Stockholders’ equity
= (3,389 + 3,242 + 3,170 + 3,244) ÷ 17,850 = 0.73

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Boston Scientific Corp. equity turnover ratio improved from Q3 2022 to Q4 2022 and from Q4 2022 to Q1 2023.